Prognos is a healthcare technology company using AI and advanced analytics. More than 7 Billion data points, 135 million patient files, and 500 proprietary algorithms put into play to drive early detection of chronic and ID-delayed diseases.
Merck is onboard with investment…Cigna has rolled it out…and we have their CMO Dr. Jason Bhan with us today.
In this episode, Dr. Steve and Dr. Bhan discuss:
- The power of Prognos’ AI platform and risk-assessment engine
- Prognos vs. IBM’s Watson
- A wide reach into life science, payer, and diagnostics industries
- Their bold new approach into early disease detection